S'abonner

Comparison of the Efficacy and Safety of Single-Site Laparoscopic Hysterectomy with and without Robotic Assistance: A Meta-Analysis - 26/02/26

Doi : 10.1016/j.jogoh.2026.103145 
Greg Marchand a, , Hollie Ulibarri a, Amanda Arroyo a, Daniela Gonzalez Herrera a, Brooke Hamilton a, Kate Ruffley a, Mckenna Robinson a, Elianna Emerson b, Anna Sabin b, Sara Kayser b, Ali Azadi c, d
a Marchand Institute for Minimally Invasive Surgery, Mesa, Arizona, USA 
b Midwestern University College of Osteopathic Medicine, Glendale, Arizona 
c University of Arizona, College of Medicine, Phoenix, Arizona 
d Creighton University, School of Medicine, Phoenix, Arizona 

Corresponding author: Dr. Greg J. Marchand, MD, FACS, FACOG, FICS, Marchand Institute for Minimally Invasive Surgery, 10238 E. Hampton, Ste. 212, Mesa, AZ 85209, 4809990905, 4809990801 Marchand Institute for Minimally Invasive Surgery 10238 E. Hampton, Ste. 212 Mesa AZ 85209

Abstract

Objective

Minimally invasive surgery (MIS) is quickly becoming standard in many benign pathologies and early-stage malignancies. We sought to compare the outcomes of robotic single-site hysterectomy (RSSH) versus laparoendoscopic single-site hysterectomy (LESS-H) in terms of operative time, estimated blood loss (EBL), length of hospital stay, pain scores, hysterectomy time, complications, conversion rates, and transfusion rates.

Data Sources

Our study was conducted following PRISMA guidelines. Our search included Web of Science, Medline, PubMed, Cochrane Library, ClinicalTrials.Gov and SCOPUS. We searched from each database’s inception until July 1st 2024.

Study eligibility criteria

We included all observational studies comparing RSSH and LESS-H. Operative time, estimated blood loss (EBL), length of hospital stay, VAS pain scores, incidence of blood transfusion, and intra-operative and postoperative complications were our predetermined outcomes.

Study appraisal and synthesis methods

Statistical analysis was done using Review Manager Software v5.9.7.

Results

RSSH was associated with a longer operative time compared to LESS-H (MD = 16.02 min, 95% CI [-0.07, 32.11], P = 0.05), with significant heterogeneity (I² = 89%). Subgroup analysis showed significantly longer operative time with RSSH for benign cases (MD = 23.51 min, 95% CI [5.79, 41.22], P = 0.009; I² = 86%) but a non-significant shorter time for early-stage endometrial carcinoma cases (MD = -10.94 min, 95% CI [-28.53, 6.64], P = 0.22; I² = 0). RSSH was associated with modestly lower EBL compared to LESS-H (MD = -6.84 ml, 95% CI [-12.34, -1.34], P = 0.01; I² = 0), though the clinical importance of this small difference remains uncertain. There was no significant difference in length of hospital stay (MD = -0.05 days, 95% CI [-0.57, 0.46], P = 0.84), pain scores at 1 hour (MD = 1.55, P = 0.26) or 12 h (MD = -0.02, P = 0.91), operative time specific to hysterectomy (MD = 2.75 min, P = 0.72), or complication rates (risk ratio = 1.161, 95% CI [0.588, 2.291], P = 0.667). Conversion and transfusion rates were also comparable between the two techniques.

Conclusion

RSSH showed modestly lower estimated blood loss but longer operative time in benign cases compared with LESS-H, with otherwise similar safety profiles; however, substantial heterogeneity and the observational nature of the evidence limit firm conclusions on superiority.

Le texte complet de cet article est disponible en PDF.

Keywords : Robotic single-site hysterectomy, Laparoendoscopic single-site hysterectomy, Meta-analysis, Operative time, Estimated blood loss, Length of hospital stay, Postoperative complications, Benign gynecologic conditions, Endometrial carcinoma, Surgical outcomes, Comparative efficacy


Plan


  www.marchandinstitute.org
  Article Type: Systematic Review and Meta-Analysis
  Condensation page
1. Tweetable statement: The latest meta-analysis from @MarchandSurgery shows that robotic single-site hysterectomy (RSSH) and laparoendoscopic single-site hysterectomy (LESS-H) appear comparable in safety and recovery for hysterectomy, with modestly lower estimated blood loss but longer operative time in benign cases with RSSH; however, considerable heterogeneity and observational limitations prevent definitive superiority claims.
2. Short Title: Comparison of the Efficacy and Safety of Robotic Single-Site versus Laparoendoscopic Single-Site Hysterectomy
A. Why was this study conducted? As minimally invasive gynecologic surgery advances, single-site laparoscopic approaches, both with and without robotic assistance, are becoming more common. Our authors wanted to compare the safety and efficacy of these techniques in an objective, pooled manner.
B. What are the key findings? RSSH was associated with modestly lower estimated blood loss but longer operative time compared to LESS-H in benign cases, with otherwise comparable outcomes for hospital stay, pain, complications, conversion, and transfusion rates.
C. What does this study add to what is already known? This study adds the largest pooled comparison to date (1113 patients) of RSSH versus LESS-H, extending prior smaller analyses while highlighting persistent heterogeneity and the need for cautious interpretation given the observational design.


© 2026  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 55 - N° 5

Article 103145- mai 2026 Retour au numéro
Article précédent Article précédent
  • Video article retrorectal endometriotic lesion involving sacral roots: Surgical technique for nerve-sparing excision and pain relief
  • Lucía Chaul, Alejandro M. González, Noelia Napoli
| Article suivant Article suivant
  • Dyspareunia and sexual dysfunction after transvaginal specimen extraction - A systematic review
  • Cihan Kaya, Tugba Saka, Hussein AlAli, Murat Yassa, Hamza Al-Amoosh, Moayyad Younis, Baydaa Al Sannan

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.